文献速递神经核医学

常规实践中药物对[123I]I-FP-CIT SPECT多巴胺转运体显像的影响

Effects of medication on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-12-20

研究纳入2019年9月至2022年12月连续接受360° CZT相机[123I]I-FP-CIT SPECT/CT扫描的305例患者,由两名核医学医师盲法视觉判读并结合本地正常数据库半定量分析。结果显示,在视觉判读正常的扫描中,去甲肾上腺素能和特异性5-羟色胺能抗抑郁药(NASSA,n=15)及曲马多(n=6)使纹状体/枕叶摄取比值降低;在半定量分析中NASSA和曲马多影响纹状体/枕叶比值,但视觉判读仅NASSA显著影响解读。

要点

  • 在视觉判读正常的扫描中,NASSA(n=15)使纹状体/枕叶比值z值为-0.93,曲马多(n=6)z值为-0.85。
  • 总体人群中,纹状体/枕叶比值受NASSA影响,并与视觉分析、年龄、性别及与疾病状态相关的抗帕金森药物相关。
  • 视觉判读时,仅NASSA显著影响[123I]I-FP-CIT SPECT的解读。

核心结论

  • 研究证实抗抑郁药(NASSA)和阿片类药物(曲马多)可能影响[123I]I-FP-CIT SPECT的半定量分析。
  • 视觉分析时,仅NASSA显著影响[123I]I-FP-CIT SPECT的解读。

研究设计与样本

  • 连续纳入2019年9月至2022年12月接受360° CZT相机[123I]I-FP-CIT SPECT/CT扫描的患者。
  • 共纳入305例患者(平均年龄71.0±10.4岁,女性135例),其中145例(47.5%)视觉判读为正常。
  • 两名经验丰富的核医学医师在不知晓用药报告的情况下进行视觉判读,并使用本地正常数据库进行半定量分析。
  • 对患者用药(抗抑郁药、抗精神病药、抗癫痫药、抗帕金森药、苯二氮䓬类、锂剂、阿片类及兴奋剂)进行了详尽审查。

主要发现

  • 在视觉判读正常的扫描中,NASSA(n=15)使纹状体/枕叶放射性配体摄取比值降低,z值为-0.93。
  • 在视觉判读正常的扫描中,曲马多(n=6)使纹状体/枕叶放射性配体摄取比值降低,z值为-0.85。
  • 多因素分析中,正常扫描的纹状体/枕叶比值与较年轻年龄相关。
  • 在总体人群中,纹状体/枕叶比值受NASSA影响,并与视觉分析、年龄、性别及与疾病状态相关的抗帕金森药物相关。

关键数值与推荐

  • 视觉判读正常的扫描中,NASSA组(n=15)纹状体/枕叶比值z值为-0.93。
  • 视觉判读正常的扫描中,曲马多组(n=6)纹状体/枕叶比值z值为-0.85。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Dopamine transporter (DAT) imaging is used to support the diagnosis of neurodegenerative parkinsonian disorders. Specific medications have been reported to confound the interpretation of [123I]I-FP-CIT SPECT scans, but there is limited data. The aim of the current study is to identify potential medication effects on the interpretation of [123I]I-FP-CIT SPECT scans in routine practice. MATERIALS AND METHODS: Consecutive patients undergoing a [123I]I-FP-CIT SPECT/CT scan on a 360° CZT camera between September 2019 and December 2022 were included. An exhaustive review of patient medications (antidepressants, antipsychotics, anti-epileptics, anti-parkinsonians, benzodiazepines, lithium, opioids, and stimulants) was performed. Two experienced nuclear physicians, blinded to the medication reports, interpreted the [123I]I-FP-CIT SPECT scans visually and a semi-quantitative analysis was performed using a local normal database. RESULTS: The study included 305 patients (71.0 ± 10.4, 135 women) and 145 (47.5%) visually interpreted normal scans. In normal scans, the striatum/occiput radioligand uptake ratio was decreased by noradrenergic and specific serotonergic antidepressants (NASSAs) (n = 15, z-score of - 0.93) and opioid medication (tramadol, n = 6, z-score of - 0.85) and was associated with a younger age in the multivariate analysis. In the overall population, the striatum/occiput ratio was influenced by NASSAs and associated with consensual visual analysis, age, sex, and anti-parkinsonian medications related to the status of the disease. CONCLUSION: Our study confirms the potential impact of antidepressant (NASSA) and opioid (tramadol) medications on the semi-quantitative analysis of [123I]I-FP-CIT SPECT scans. However, when performing a visual analysis, only NASSAs significantly impacted the interpretation of [123I]I-FP-CIT SPECT scans.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Piatkova Y, Doyen M, Heyer S, et al. Effects of medication on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice. Eur J Nucl Med Mol Imaging. 2023. PMID: 38114618. doi:10.1007/s00259-023-06565-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。